Halocarbon (River Edge, NJ) has carved out a profitable niche in fluorine chemistry, leveraging 60 years of expertise to build positions in specialty fluorochemicals, inhalation anesthetics, and inert oils, waxes, and greases. The privately held company does not disclose sales, but says revenues are in the tens of millions of dollars per year. Growth has been strong, at 20% in 2010, due to the addition of new chemistries, and early indications show the company is on track to post similar results for full-year 2011. Fluorochemicals make up about half of Halocarbon’s sales, with anesthetics and oils, greases, and waxes accounting for the remaining 30% and 20%, respectively. Exports accounted for just under 60% of the company’s revenue last year.